Role of the Hydrogen Bonding Heteroatom-Lys53 Interaction between the p38α Mitogen-Activated Protein (MAP) Kinase and Pyridinyl-Substituted 5-Membered Heterocyclic Ring Inhibitors

被引:24
作者
Abu Thaher, Bassam [2 ]
Koch, Pierre [1 ]
Schattel, Verena [1 ]
Laufer, Stefan [1 ]
机构
[1] Univ Tubingen, Inst Pharm, Dept Pharmaceut & Med Chem, D-72076 Tubingen, Germany
[2] Islam Univ Gaza, Dept Chem, Fac Sci, Gaza, Israel
关键词
STRUCTURAL BASIS; P38; INHIBITORS; IMIDAZOLES; MOLECULES;
D O I
10.1021/jm801467h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the framework of Investigating the role of heteroatoms in pyridinyl-substituted 5-membered (hetero)cycles as potential p38 alpha MAP kinase inhibitor scaffolds, cyclopentene, pyrrole, furan, and imidazole analogues were synthesized and tested with respect to their ability to inhibit p38a MAP kinase. The vicinal pyridine/4-fluorophenyl pharmacophore was conserved, such as in the prototypical imidazole inhibitor SB203580. The strength of the HB interaction was calculated and compared to the biological data.
引用
收藏
页码:2613 / 2617
页数:5
相关论文
共 26 条
[1]   A convenient synthesis of 1-(4-fluorophenyl)-2-(4-pyridyl)cyclopentene from cyclopentanone [J].
Abu Thaher, Bassam ;
Koch, Pierre ;
Del Amo, Vicente ;
Knochel, Paul ;
Laufer, Stefan .
SYNTHESIS-STUTTGART, 2008, (02) :225-228
[2]   4-[2-(4-Fluorophenyl)furan-3-yl]pyridine [J].
Abu Thaher, Bassam ;
Koch, Pierre ;
Schollmeyer, Dieter ;
Laufer, Stefan .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 :O458-U1236
[3]   4-[2-(4-Fluorophenyl)-1H-pyrrol-3-yl]pyridine [J].
Abu Thaher, Bassam ;
Koch, Pierre ;
Schollmeyer, Dieter ;
Laufer, Stefan .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 :O457-U1226
[4]   1-substituted 4-aryl-5-pyridinylimidazoles: A new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency [J].
Boehm, JC ;
Smietana, JM ;
Sorenson, ME ;
Garigipati, RS ;
Gallagher, TF ;
Sheldrake, PL ;
Bradbeer, J ;
Badger, AM ;
Laydon, JT ;
Lee, JC ;
Hillegass, LM ;
Griswold, DE ;
Breton, JJ ;
ChabotFletcher, MC ;
Adams, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) :3929-3937
[5]   Potent, orally absorbed glucagon receptor antagonists [J].
de Laszlo, SE ;
Hacker, C ;
Li, B ;
Kim, D ;
MacCoss, M ;
Mantlo, N ;
Pivnichny, JV ;
Colwell, L ;
Koch, GE ;
Cascieri, MA ;
Hagmann, WK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (05) :641-646
[6]   Pyrroles and other heterocycles as inhibitors of p38 kinase [J].
de Laszlo, SE ;
Visco, D ;
Agarwal, L ;
Chang, L ;
Chin, J ;
Croft, G ;
Forsyth, A ;
Fletcher, D ;
Frantz, B ;
Hacker, C ;
Hanlon, W ;
Harper, C ;
Kostura, M ;
Li, B ;
Luell, S ;
MacCoss, M ;
Mantlo, N ;
O'Neill, EA ;
Orevillo, C ;
Pang, M ;
Parsons, J ;
Rolando, A ;
Sahly, Y ;
Sidler, K ;
Widmer, WR ;
O'Keefe, SJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (19) :2689-2694
[7]   Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity [J].
Fitzgerald, CE ;
Patel, SB ;
Becker, JW ;
Cameron, PM ;
Zaller, D ;
Pikounis, VB ;
O'Keefe, SJ ;
Scapin, G .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) :764-769
[8]   Regulation of stress-induced cytokine production by pyridinylimidazoles; Inhibition of CSBP kinase [J].
Gallagher, TF ;
Seibel, GL ;
Kassis, S ;
Laydon, JT ;
Blumenthal, MJ ;
Lee, JC ;
Lee, D ;
Boehm, JC ;
FierThompson, SM ;
Abt, JW ;
Soreson, ME ;
Smietana, JM ;
Hall, RF ;
Garigipati, RS ;
Bender, PE ;
Erhard, KF ;
Krog, AJ ;
Hofmann, GA ;
Sheldrake, PL ;
McDonnell, PC ;
Kumar, S ;
Young, PR ;
Adams, JL .
BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (01) :49-64
[9]   Theoretical calculation of hydrogen-bonding strength for drug molecules [J].
Hao, MH .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2006, 2 (03) :863-872
[10]   4-[5-(4-Fluorophenyl)-1H-imidazol-4-yl]pyridine [J].
Koch, Pierre ;
Schollmeyer, Dieter ;
Laufer, Stefan .
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 :O573-U2252